These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice. Yang KS; Lim JH; Kim TW; Kim MY; Kim Y; Chung S; Shin SJ; Choi BS; Kim HW; Kim YS; Chang YS; Kim HW; Park CW PLoS One; 2014; 9(4):e94540. PubMed ID: 24759928 [TBL] [Abstract][Full Text] [Related]
24. The role of VEGF-A in glomerular development and function. Eremina V; Quaggin SE Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):9-15. PubMed ID: 15090854 [TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation. Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941 [TBL] [Abstract][Full Text] [Related]
26. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944 [TBL] [Abstract][Full Text] [Related]
27. Role of vascular endothelial growth factor in kidney disease. Doi K; Noiri E; Fujita T Curr Vasc Pharmacol; 2010 Jan; 8(1):122-8. PubMed ID: 19485913 [TBL] [Abstract][Full Text] [Related]
29. A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice. Zhang Y; Nakano D; Guan Y; Hitomi H; Uemura A; Masaki T; Kobara H; Sugaya T; Nishiyama A Kidney Int; 2018 Sep; 94(3):524-535. PubMed ID: 30045814 [TBL] [Abstract][Full Text] [Related]
30. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371 [TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918 [TBL] [Abstract][Full Text] [Related]
32. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF- Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225 [TBL] [Abstract][Full Text] [Related]
33. Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Eremina V; Baelde HJ; Quaggin SE Nephron Physiol; 2007; 106(2):p32-7. PubMed ID: 17570946 [TBL] [Abstract][Full Text] [Related]
34. Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF. Burt LE; Forbes MS; Thornhill BA; Kiley SC; Minor JJ; Chevalier RL Am J Physiol Renal Physiol; 2007 Jan; 292(1):F168-74. PubMed ID: 16788139 [TBL] [Abstract][Full Text] [Related]
35. Endothelial Phospholipase Cγ2 Improves Outcomes of Diabetic Ischemic Limb Rescue Following VEGF Therapy. Rustagi Y; Abouhashem AS; Verma P; Verma SS; Hernandez E; Liu S; Kumar M; Guda PR; Srivastava R; Mohanty SK; Kacar S; Mahajan S; Wanczyk KE; Khanna S; Murphy MP; Gordillo GM; Roy S; Wan J; Sen CK; Singh K Diabetes; 2022 May; 71(5):1149-1165. PubMed ID: 35192691 [TBL] [Abstract][Full Text] [Related]
36. The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes. Bus P; Scharpfenecker M; Van Der Wilk P; Wolterbeek R; Bruijn JA; Baelde HJ Diabetologia; 2017 Sep; 60(9):1813-1821. PubMed ID: 28620823 [TBL] [Abstract][Full Text] [Related]
37. Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor. Aplin AC; Nicosia RF Angiogenesis; 2016 Apr; 19(2):133-46. PubMed ID: 26748649 [TBL] [Abstract][Full Text] [Related]
38. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy. Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264 [TBL] [Abstract][Full Text] [Related]
39. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. Sison K; Eremina V; Baelde H; Min W; Hirashima M; Fantus IG; Quaggin SE J Am Soc Nephrol; 2010 Oct; 21(10):1691-701. PubMed ID: 20688931 [TBL] [Abstract][Full Text] [Related]
40. Vascular Endothelial Growth Factor Isoform-B Stimulates Neurovascular Repair After Ischemic Stroke by Promoting the Function of Pericytes via Vascular Endothelial Growth Factor Receptor-1. Jean LeBlanc N; Guruswamy R; ElAli A Mol Neurobiol; 2018 May; 55(5):3611-3626. PubMed ID: 28290152 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]